Vranovska nemocnica a.s.
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Vranovska nemocnica a.s., clinical research in cardiovascular diseases focuses on major conditions such as atherosclerotic cardiovascular disease, elevated Lp(a), and the prevention of ischemic stroke after recent non-cardioembolic stroke or high-risk transient ischemic attack. The trials are designed to assess whether new treatments can better reduce future cardiovascular events and improve protection against serious clot-related complications.
- Testing new approaches to lower the risk of stroke after a recent ischemic event
- Evaluating treatments aimed at reducing major cardiovascular events in adults with elevated lipoprotein(a)
- Studying the effectiveness and safety of therapies added to standard antiplatelet treatment
This work reflects a strong interest in improving both prevention and long-term outcomes for patients at risk of serious cardiovascular complications.
Congenital and Hereditary Disorders
The Neurologicke oddelenie is also involved in research on congenital and hereditary diseases, especially haemophilia A with or without factor VIII inhibitors. These studies aim to better understand long-term treatment performance and support safer, more effective care for people living with this inherited bleeding disorder.
- Investigating the long-term safety of a new preventive treatment for haemophilia A
- Assessing treatment options for patients with and without FVIII inhibitors
- Expanding evidence for care in both older patients and infants with inherited bleeding risk
This area of research is particularly important for improving everyday disease control and reducing bleeding-related complications across different patient groups.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Novo Nordisk A/S1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Vranovska nemocnica a.s.
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial | Eli Lilly & Co. | Phase III | Not Recruiting | Apr 2026 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Asundexian | 1 | Unknown | 2023-01-18 | 2023-01-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.